Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR1 | P30872 | 1/20 | 0.70 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.70 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.70 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.70 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.70 |
| ▸ | NT5E | P21589 | 1/20 | 0.55 |
| ▸ | GJB2 | P29033 | 1/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 9/20 | 0.54 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.54 |
| ▸ | BCHE | P06276 | 1/20 | 0.54 |
| ▸ | CDC25B | P30305 | 6/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.49 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31491488 | 1.00 | SSTR1 (0.70) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL15338590 | 1.00 | SSTR1 (0.70) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL1957129 | 1.00 | SSTR1 (0.70) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL3752668 | 1.00 | SSTR1 (0.70) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL13204994 | 1.00 | SSTR1 (0.70) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL13591468 | 1.00 | SSTR1 (0.70) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL12896361 | 1.00 | SSTR1 (0.70) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL3752664 | 1.00 | SSTR1 (0.70) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL6872203 | 1.00 | SSTR1 (0.70) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL30928985 | 1.00 | SSTR1 (0.70) | SSTR1SSTR2SSTR4SSTR3SSTR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1283211-B1 | L-Nucleosides for the treatment of hepatitis B-virus and Epstein-barr virus | UNIV GEORGIA RES FOUND (US) | 2006-06-07 | — | — | EP | disclosed |
| EP-0748330-B1 | L-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B-VIRUS AND EPSTEIN-BAR VIRUS | UNIV GEORGIA RES FOUND (US) | 2003-04-02 | — | — | EP | disclosed |
| EP-1283211-A2 | L-Nucleosides for the treatment of hepatitis B-virus and Epstein-barr virus | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2003-02-12 | — | — | EP | disclosed |
| US-5808040-A | VIRICIDES | YALE UNIVERSITY (US) | 1998-09-15 | — | — | US | disclosed |
| US-5753789-A | Oligonucleotides containing L-nucleosides | YALE UNIVERSITY (US) | 1998-05-19 | — | — | US | disclosed |
| US-5587362-A | VIRICIDES FOR HEPATITIS VIRUS AND EPSTEIN-BAR VIRUS | UNIV. OF GA RESEARCH FOUNDATION (US) | 1996-12-24 | — | — | US | disclosed |
| EP-0748330-A1 | L-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B-VIRUS AND EPSTEIN-BAR VIRUS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1996-12-18 | — | — | EP | disclosed |
| US-5567688-A | ADMINISTERING SPECIFIED ENANTIOMORPH TO HUMAN INFECTED WITH HEPATITIS B VIRUS | UNIV. OF GA RESEARCH FOUNDATION (US) | 1996-10-22 | — | — | US | disclosed |
| US-5565438-A | L-nucleosides for the treatment of epstein-bar virus | UNIVERSITY OF GA RESEARCH FOUNDATION (US) | 1996-10-15 | — | — | US | disclosed |
| WO-1995020595-A1 | L-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B-VIRUS AND EPSTEIN-BAR VIRUS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1995-08-03 | — | — | WO | disclosed |